GNPX Genprex Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GNPX

Price (delayed)

$2.44

Market cap

$4.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$22.56

Enterprise value

-$2.08M

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new ...

Highlights
The company's EPS fell by 14% YoY but it rose by 7% QoQ
GNPX's quick ratio has dropped by 72% year-on-year and by 23% since the previous quarter
Genprex's equity has plunged by 67% YoY and by 40% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.genprex.com
Peers: OMER OMGA

Key stats

What are the main financial stats of GNPX
Market
Shares outstanding
1.91M
Market cap
$4.66M
Enterprise value
-$2.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$30.86M
EBITDA
-$30.85M
Free cash flow
-$24.74M
Per share
EPS
-$22.56
Free cash flow per share
-$18.09
Book value per share
$4.99
Revenue per share
$0
TBVPS
$7.24
Balance sheet
Total assets
$10.67M
Total liabilities
$3.25M
Debt
$0
Equity
$7.42M
Working capital
$4.28M
Liquidity
Debt to equity
0
Current ratio
2.31
Quick ratio
2.07
Net debt/EBITDA
0.22
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-185.5%
Return on equity
-245.6%
Return on invested capital
-16,035.7%
Return on capital employed
-416.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GNPX stock price

How has the Genprex stock price performed over time
Intraday
3.83%
1 week
10.91%
1 month
-21.54%
1 year
204.62%
YTD
960.87%
QTD
-18.12%

Financial performance

How have Genprex's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.08M
Net income
-$30.86M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 30% YoY
The net income has declined by 30% year-on-year

Growth

What is Genprex's growth rate over time

Valuation

What is Genprex stock price valuation
P/E
N/A
P/B
0.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 14% YoY but it rose by 7% QoQ
The P/B is 84% below the 5-year quarterly average of 3.1 and 81% below the last 4 quarters average of 2.6
Genprex's equity has plunged by 67% YoY and by 40% from the previous quarter

Efficiency

How efficient is Genprex business performance
GNPX's ROA has plunged by 152% YoY and by 19% from the previous quarter
The company's return on invested capital has shrunk by 89% QoQ
The ROE fell by 27% QoQ

Dividends

What is GNPX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GNPX.

Financial health

How did Genprex financials performed over time
GNPX's quick ratio has dropped by 72% year-on-year and by 23% since the previous quarter
GNPX's current ratio has dropped by 70% year-on-year and by 22% since the previous quarter
Genprex's debt is 100% lower than its equity
Genprex's equity has plunged by 67% YoY and by 40% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.